Your browser doesn't support javascript.
loading
Effects of coenzyme Q10 on ovarian surface epithelium-derived ovarian stem cells and ovarian function in a 4-vinylcyclohexene diepoxide-induced murine model of ovarian failure.
Lee, Hyun Joo; Park, Min Jung; Joo, Bo Sun; Joo, Jong Kil; Kim, Yeon Hee; Yang, Sun Woo; Kim, Chang-Woon; Kim, Ki Hyung.
Afiliação
  • Lee HJ; Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.
  • Park MJ; Biomedical Research Institute, Pusan National University Hospital, Busan, 49241, Republic of Korea.
  • Joo BS; The Korea Institute for Public Sperm Bank, Busan, Republic of Korea.
  • Joo JK; The Korea Institute for Public Sperm Bank, Busan, Republic of Korea.
  • Kim YH; Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.
  • Yang SW; Biomedical Research Institute, Pusan National University Hospital, Busan, 49241, Republic of Korea.
  • Kim CW; Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwoon, Kyungsang Nam-Do, Republic of Korea.
  • Kim KH; Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwoon, Kyungsang Nam-Do, Republic of Korea.
Reprod Biol Endocrinol ; 19(1): 59, 2021 Apr 22.
Article em En | MEDLINE | ID: mdl-33888135
ABSTRACT

BACKGROUND:

Several studies have shown that coenzyme Q10 (CoQ10) can rescue ovarian aging and that ovarian surface epithelium (OSE)-derived ovarian stem cells (OSCs) are useful for treating infertility due to ovarian aging. However, few studies have examined the effect of CoQ10 on OSCs. This study was aimed to investigate whether CoQ10 activates OSCs and recovers ovarian function in a 4-vinylcyclohexene diepoxide (VCD)-induced mouse model of ovarian failure.

METHODS:

Forty female C57BL/6 mice aged 6 weeks were randomly divided into four groups (n = 10/group) a control group administered saline orally, a CoQ10 group administered 150 mg/kg/day of CoQ10 orally in 1 mL of saline daily for 14 days, a VCD group administered 160 mg/kg/day of VCD i.p. in 2.5 mL of saline/kg for 5 days, and a VCD + CoQ10 group administered VCD i.p. for 5 days injection and CoQ10 (150 mg/kg/day) orally for 14 days. After treatment, follicle counts were evaluated by hematoxylin and eosin (H&E) staining, and ovarian mRNA expressions of Bmp-15, Gdf-9, and c-Kit were examined by quantitative real-time PCR. Serum FSH, AMH, and ROS levels were also measured. Oocyte-like structure counts and the expressions of Oct-4 and MVH were also evaluated after culturing OSE for 3 weeks. In a second experiment, 32 female mice were administered CoQ10 as described above, induced to superovulate using PMSG and hCG, and mated. Numbers of zygotes and embryo development rate were examined.

RESULTS:

Postcultured OSE showed significant increases in the numbers of oocyte-like structure and that the expression of Oct-4 and MVH were higher in the VCD + CoQ10 group than in the VCD group (p < 0.05). Numbers of surviving follicles from primordial to antral follicles, numbers of zygotes retrieved and embryo development rate to blastocyst were significantly greater in the VCD + CoQ10 group than in the VCD group (p < 0.01). Serum AMH level and ovarian expressions of Bmp-15, Gdf-9 and c-Kit were also significantly greater in the VCD + CoQ10 group than in the VCD group (p < 0.05). In contrast, serum ROS level was significantly lower in the VCD + CoQ10 group than in the VCD group (p < 0.05).

CONCLUSION:

This study shows that CoQ10 stimulates the differentiation of OSE-derived OSCs and confirms that CoQ10 can reduce ROS levels and improve ovarian function and oocyte quality in mice with VCD-induced ovarian failure.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ovarianas / Ovário / Ubiquinona Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ovarianas / Ovário / Ubiquinona Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article